Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.

Autores:: Cabrales Dajil, Heriberto José
De la Vega del Risco, Fernando
Coronado Daza, Jorge

Tipo de recurso:: Article of journal

Fecha de publicación:: 2019

Institución:: Universidad de Cartagena

Repositorio:: Repositorio Universidad de Cartagena

Idioma:: spa

id	UCART2_0211ddf3d3ee1a0708dbc8e98df66d2d
oai_identifier_str	oai:repositorio.unicartagena.edu.co:11227/13082
network_acronym_str	UCART2
network_name_str	Repositorio Universidad de Cartagena
repository_id_str
dc.title.spa.fl_str_mv	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.
dc.title.translated.eng.fl_str_mv	Risk factors associated with chronic kidney disease in patients with HIV infection.
title	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.
spellingShingle	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH. Enfermedad renal crónica VIH Nefrotoxicidad Chronic kidney insufficiency HIV Nephrotoxicity
title_short	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.
title_full	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.
title_fullStr	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.
title_full_unstemmed	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.
title_sort	Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.
dc.creator.fl_str_mv	Cabrales Dajil, Heriberto José De la Vega del Risco, Fernando Coronado Daza, Jorge
dc.contributor.author.spa.fl_str_mv	Cabrales Dajil, Heriberto José De la Vega del Risco, Fernando Coronado Daza, Jorge
dc.subject.spa.fl_str_mv	Enfermedad renal crónica VIH Nefrotoxicidad
topic	Enfermedad renal crónica VIH Nefrotoxicidad Chronic kidney insufficiency HIV Nephrotoxicity
dc.subject.eng.fl_str_mv	Chronic kidney insufficiency HIV Nephrotoxicity
publishDate	2019
dc.date.accessioned.none.fl_str_mv	2019-07-15 00:00:00
dc.date.available.none.fl_str_mv	2019-07-15 00:00:00
dc.date.issued.none.fl_str_mv	2019-07-15
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	2215-7840
dc.identifier.doi.none.fl_str_mv	10.32997/rcb-2019-2874
dc.identifier.eissn.none.fl_str_mv	2389-7252
dc.identifier.url.none.fl_str_mv	https://doi.org/10.32997/rcb-2019-2874
identifier_str_mv	2215-7840 10.32997/rcb-2019-2874 2389-7252
url	https://doi.org/10.32997/rcb-2019-2874
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Ciencias Biomédicas
dc.relation.bitstream.none.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2874/2417
dc.relation.citationedition.spa.fl_str_mv	Núm. 2 , Año 2019
dc.relation.citationendpage.none.fl_str_mv	86
dc.relation.citationissue.spa.fl_str_mv	2
dc.relation.citationstartpage.none.fl_str_mv	72
dc.relation.citationvolume.spa.fl_str_mv	8
dc.relation.references.spa.fl_str_mv	Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV medicine. 2017; 18(4): 256-66. https://doi.org/10.1111/hiv.12421 Justice AC, Dombrowski E, Conigliaro J, Fultz SL, Gibson D, Madenwald T, et al. Veterans Aging Cohort Study (VACS): Overview and Description. Medical care. 2006; 44(8 Suppl 2): S13-S24. https://doi.org/10.1097/01.mlr.0000223741.02074.66 Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. Aids. 2007; 21(15): 2101-3. https://doi.org/10.1097/QAD.0b013e3282ef1bb4 Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fatkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. Aids. 2015; 29(2): 221-9. https://doi.org/10.1097/QAD.0000000000000540 Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem Av, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. The Lancet Infectious Diseases. 2015; 15(7): 810-8. https://doi.org/10.1016/S1473-3099(15)00056-0 Palella FJ, Jr., Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of acquired immune deficiency syndromes (1999). 2006; 43(1): 27-34. https://doi.org/10.1097/01.qai.0000233310.90484.16 Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV medicine. 2008; 9(7): 535-43. https://doi.org/10.1111/j.1468-1293.2008.00600.x Martinez E, Milinkovic A, Buira E, de Lazzari E, Leon A, Larrousse M, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV medicine. 2007; 8(4): 251-8. https://doi.org/10.1111/j.1468-1293.2007.00468.x Ehren K, Hertenstein C, Kummerle T, Vehreschild JJ, Fischer J, Gillor D, et al. Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection. 2014; 42(1): 135-40. https://doi.org/10.1007/s15010-013-0535-7 Kaufman L, Collins SE, Klotman PE. The pathogenesis of HIV-associated nephropathy. Advances in chronic kidney disease. 2010; 17(1): 36-43. https://doi.org/10.1053/j.ackd.2009.08.012 Stokes MB, Chawla H, Brody RI, Kumar A, Gertner R, Goldfarb DS, et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1997; 29(4): 514-25. https://doi.org/10.1016/S0272-6386(97)90332-2 Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, et al. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. Aids. 2012; 26(15): 1917-26. https://doi.org/10.1097/QAD.0b013e3283574e71 Suzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, et al. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naive Asian Patients: Results from 12-Year Observational Cohort. AIDS patient care and STDs. 2017; 31(3): 105-12. https://doi.org/10.1089/apc.2016.0286 Achhra AC, Mocroft A, Ross MJ, Ryom L, Lucas GM, Furrer H, et al. Kidney disease in antiretroviral-naive HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV medicine. 2015; 16 Suppl 1: 55-63. https://doi.org/10.1111/hiv.12234 Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, et al. Chronic renal failure among HIV-1-infected patients. Aids. 2007; 21(9): 1119-27. https://doi.org/10.1097/QAD.0b013e3280f774ee Crum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS patient care and STDs. 2010; 24(6): 353-60. https://doi.org/10.1089/apc.2009.0326 Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. Aids. 2010; 24(11): 1667-78. https://doi.org/10.1097/QAD.0b013e328339fe53 Moso MA, Woolnough E, Langham F, Hoy JF, Cheng AC, Walker RG, et al. Increasing prevalence and risk of chronic kidney disease in HIV-positive individuals: changing demographics over a six-year period. The Journal of infectious diseases. 2017. https://doi.org/10.1093/infdis/jix676 Calza L, Vanino E, Magistrelli E, Salvadori C, Cascavilla A, Colangeli V, et al. Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. Clinical and Experimental Nephrology. 2014; 18(1): 104-12. https://doi.org/10.1007/s10157-013-0817-5 Otero A, de Francisco A, Gayoso P, Garcia F. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrología : publicación oficial de la Sociedad Española Nefrología. 2010; 30(1): 78-86. Social MdSyP. ANALISIS DE SITUACIÓN DE SALUD (ASIS) COLOMBIA. Disponible en: https://www.minsaludgovco/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/asis-colombia-2016pdf 2016. Nishijima T, Kawasaki Y, Mutoh Y, Tomonari K, Tsukada K, Kikuchi Y, et al. Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo. Scientific reports. 2017; 7(1): 14565. https://doi.org/10.1038/s41598-017-15214-x Mallipattu SK, Salem F, Wyatt CM. The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney Int. 2014; 86(2): 259-65. https://doi.org/10.1038/ki.2014.44 Ikpeme EE, Ekrikpo UE, Akpan MU, Ekaidem SI. Determining the prevalence of human immunodeficiency virus-associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population. The Pan African medical journal. 2012; 11:13. Scherzer R, Estrella M, Li Y, Choi AI, Deeks SG, Grunfeld C, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. Aids. 2012; 26(7): 867-75. https://doi.org/10.1097/QAD.0b013e328351f68f Rho M, Perazella MA. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Current drug safety. 2007; 2(2): 147-54. https://doi.org/10.2174/157488607780598269 Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, et al. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. The Journal of infectious diseases. 2008; 197(1): 102-8. https://doi.org/10.1086/524061 Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, et al. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. The lancet HIV. 2016; 3(1): e23-32. https://doi.org/10.1016/S2352-3018(15)00211-8 Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS (London, England). 2012; 26(15): 1907-15. https://doi.org/10.1097/QAD.0b013e328357f5ed Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clinical chemistry. 1992; 38(10): 1933-53. https://doi.org/10.1093/clinchem/38.10.1933 Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985; 28(5): 830-8. https://doi.org/10.1038/ki.1985.205 Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine. 1999; 130(6): 461-70. https://doi.org/10.7326/0003-4819-130-6-199903160-00002 Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009; 150(9): 604-12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006 Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical chemistry. 2007; 53(4): 766-72. https://doi.org/10.1373/clinchem.2006.077180 Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, Hoek FJ, et al. A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clinical nephrology. 2012; 77(4): 311-20. https://doi.org/10.5414/CN107214 Cristelli MP, Cofan F, Rico N, Trullas JC, Manzardo C, Aguero F, et al. Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis. BMC nephrology. 2017; 18(1): 58. https://doi.org/10.1186/s12882-017-0470-4 Gagneux-Brunon A, Botelho-Nevers E, Delanaye P, Lucht F, Fresard A, Cazorla C, et al. CKD-EPI equation: A suitable Glomerular Filtration Rate estimate for drug dosing in HIV-infected patients. Medecine et maladies infectieuses. 2017. https://doi.org/10.1016/j.medmal.2017.04.001 Okparavero AA, Tighiouart H, Krishnasami Z, Wyatt CM, Graham H, Hellinger J, et al. Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients. Antiviral therapy. 2013; 18(6): 793-802. https://doi.org/10.3851/IMP2676 Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, et al. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2014; 59(9): e96-e138. https://doi.org/10.1093/cid/ciu617 Andrassy KM. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. Kidney Int. 2013; 84(3): 622-3. https://doi.org/10.1038/ki.2013.243 Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of internal medicine. 2013; 158(11): 825-30. https://doi.org/10.7326/0003-4819-158-11-201306040-00007 Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014; 63(5): 713-35. https://doi.org/10.1053/j.ajkd.2014.01.416 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 2003; 289(19): 2560-72. https://doi.org/10.1001/jama.289.19.2560 2. Classification and Diagnosis of Diabetes. Diabetes care. 2017; 40(Suppl 1): S11-s24. https://doi.org/10.2337/dc17-S005 Diaz K. PREVALENCIA DE ALTERACIÓN RENAL EN UNA POBLACIÓN AMBULATORIA CON VIH-SIDA DE CARTAGENA (TRABAJO DE GRADO). Universidad de Cartagena, Bolívar, Colombia. 2009. Costo FCdEdA. Situación de la Enfermedad Renal Crónica, la hipertensión arterial y la diabetes mellitus en Colombia 2016. Cuenta de Alto Costo. 2017: 57,107. Lamb EJ, O'Riordan SE, Delaney MP. Kidney function in older people: pathology, assessment and management. Clin Chim Acta. 2003; 334(1-2): 25-40. https://doi.org/10.1016/S0009-8981(03)00246-8 Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic Kidney Disease Incidence, and Progression to End-Stage Renal Disease, in HIV-Infected Individuals: A Tale of Two Races. The Journal of infectious diseases. 2008; 197(11): 1548-57. https://doi.org/10.1086/587994 Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV medicine. 2009; 10(6): 343-50. https://doi.org/10.1111/j.1468-1293.2009.00693.x Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. The American journal of the medical sciences. 2008; 335(2): 89-94. https://doi.org/10.1097/MAJ.0b013e31812e6b34 Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. Jama. 2007; 298(17): 2038-47. https://doi.org/10.1001/jama.298.17.2038 Grams ME, Juraschek SP, Selvin E, Foster MC, Inker LA, Eckfeldt JH, et al. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013; 62(2): 253-60. https://doi.org/10.1053/j.ajkd.2013.03.013 Chapter 2: Definition, identification, and prediction of CKD progression. Kidney International Supplements. 2013; 3(1): 63-72. https://doi.org/10.1038/kisup.2012.65 Winocour PH. Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care. Diabetic medicine : a journal of the British Diabetic Association. 2017. https://doi.org/10.1111/dme.13564 Medapalli R, Parikh CR, Gordon K, Brown ST, Butt AA, Gibert CL, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: Data from the Veterans Aging Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2012; 60(4): 393-9. https://doi.org/10.1097/QAI.0b013e31825b70d9 Squires K, Pozniak AL, Pierone G, Jr., Steinhart CR, Berger D, Bellos NC, et al. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial. Annals of internal medicine. 2003; 139(5 Pt 1): 313-20. https://doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00006 Jones R, Stebbing J, Nelson M, Moyle G, Bower M, Mandalia S, et al. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. Journal of acquired immune deficiency syndromes (1999). 2004; 37(4): 1489-95. https://doi.org/10.1097/01.qai.0000138983.45235.02 Kooij KW, Vogt L, Wit F, van der Valk M, van Zoest RA, Goorhuis A, et al. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. The Journal of infectious diseases. 2017; 216(6): 622-31. https://doi.org/10.1093/infdis/jix202 Social MdSyP. Guía para el Manejo del VIH/SIDA - Basada en la Evidencia - COLOMBIA. 2014. Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodríguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. Aids. 2012; 26(15): 1907-15. https://doi.org/10.1097/QAD.0b013e328357f5ed
dc.rights.spa.fl_str_mv	Revista Ciencias Biomédicas - 2019
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Revista Ciencias Biomédicas - 2019 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Cartagena
dc.source.spa.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2874
institution	Universidad de Cartagena
bitstream.url.fl_str_mv	https://repositorio.unicartagena.edu.co/bitstreams/b06568d2-ffa3-4cc0-a27e-a00813b847fd/download
bitstream.checksum.fl_str_mv	e5d59c61d1a32af919cc797efa562cb8
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Biblioteca Digital Universidad de Cartagena
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1814214155508383744
spelling	Cabrales Dajil, Heriberto JoséDe la Vega del Risco, FernandoCoronado Daza, Jorge2019-07-15 00:00:002019-07-15 00:00:002019-07-152215-784010.32997/rcb-2019-28742389-7252https://doi.org/10.32997/rcb-2019-2874application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2874/2417Núm. 2 , Año 2019862728Teeraananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV medicine. 2017; 18(4): 256-66. https://doi.org/10.1111/hiv.12421Justice AC, Dombrowski E, Conigliaro J, Fultz SL, Gibson D, Madenwald T, et al. Veterans Aging Cohort Study (VACS): Overview and Description. Medical care. 2006; 44(8 Suppl 2): S13-S24. https://doi.org/10.1097/01.mlr.0000223741.02074.66Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. Aids. 2007; 21(15): 2101-3. https://doi.org/10.1097/QAD.0b013e3282ef1bb4Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fatkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. Aids. 2015; 29(2): 221-9. https://doi.org/10.1097/QAD.0000000000000540Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem Av, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. The Lancet Infectious Diseases. 2015; 15(7): 810-8. https://doi.org/10.1016/S1473-3099(15)00056-0Palella FJ, Jr., Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. Journal of acquired immune deficiency syndromes (1999). 2006; 43(1): 27-34. https://doi.org/10.1097/01.qai.0000233310.90484.16Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, et al. Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005. HIV medicine. 2008; 9(7): 535-43. https://doi.org/10.1111/j.1468-1293.2008.00600.xMartinez E, Milinkovic A, Buira E, de Lazzari E, Leon A, Larrousse M, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV medicine. 2007; 8(4): 251-8. https://doi.org/10.1111/j.1468-1293.2007.00468.xEhren K, Hertenstein C, Kummerle T, Vehreschild JJ, Fischer J, Gillor D, et al. Causes of death in HIV-infected patients from the Cologne-Bonn cohort. Infection. 2014; 42(1): 135-40. https://doi.org/10.1007/s15010-013-0535-7Kaufman L, Collins SE, Klotman PE. The pathogenesis of HIV-associated nephropathy. Advances in chronic kidney disease. 2010; 17(1): 36-43. https://doi.org/10.1053/j.ackd.2009.08.012Stokes MB, Chawla H, Brody RI, Kumar A, Gertner R, Goldfarb DS, et al. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. American journal of kidney diseases : the official journal of the National Kidney Foundation. 1997; 29(4): 514-25. https://doi.org/10.1016/S0272-6386(97)90332-2Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, et al. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. Aids. 2012; 26(15): 1917-26. https://doi.org/10.1097/QAD.0b013e3283574e71Suzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, et al. Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naive Asian Patients: Results from 12-Year Observational Cohort. AIDS patient care and STDs. 2017; 31(3): 105-12. https://doi.org/10.1089/apc.2016.0286Achhra AC, Mocroft A, Ross MJ, Ryom L, Lucas GM, Furrer H, et al. Kidney disease in antiretroviral-naive HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV medicine. 2015; 16 Suppl 1: 55-63. https://doi.org/10.1111/hiv.12234Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, et al. Chronic renal failure among HIV-1-infected patients. Aids. 2007; 21(9): 1119-27. https://doi.org/10.1097/QAD.0b013e3280f774eeCrum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS patient care and STDs. 2010; 24(6): 353-60. https://doi.org/10.1089/apc.2009.0326Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. Aids. 2010; 24(11): 1667-78. https://doi.org/10.1097/QAD.0b013e328339fe53Moso MA, Woolnough E, Langham F, Hoy JF, Cheng AC, Walker RG, et al. Increasing prevalence and risk of chronic kidney disease in HIV-positive individuals: changing demographics over a six-year period. The Journal of infectious diseases. 2017. https://doi.org/10.1093/infdis/jix676Calza L, Vanino E, Magistrelli E, Salvadori C, Cascavilla A, Colangeli V, et al. Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. Clinical and Experimental Nephrology. 2014; 18(1): 104-12. https://doi.org/10.1007/s10157-013-0817-5Otero A, de Francisco A, Gayoso P, Garcia F. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrología : publicación oficial de la Sociedad Española Nefrología. 2010; 30(1): 78-86.Social MdSyP. ANALISIS DE SITUACIÓN DE SALUD (ASIS) COLOMBIA. Disponible en: https://www.minsaludgovco/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/asis-colombia-2016pdf 2016.Nishijima T, Kawasaki Y, Mutoh Y, Tomonari K, Tsukada K, Kikuchi Y, et al. Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo. Scientific reports. 2017; 7(1): 14565. https://doi.org/10.1038/s41598-017-15214-xMallipattu SK, Salem F, Wyatt CM. The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney Int. 2014; 86(2): 259-65. https://doi.org/10.1038/ki.2014.44Ikpeme EE, Ekrikpo UE, Akpan MU, Ekaidem SI. Determining the prevalence of human immunodeficiency virus-associated nephropathy (HIVAN) using proteinuria and ultrasound findings in a Nigerian paediatric HIV population. The Pan African medical journal. 2012; 11:13.Scherzer R, Estrella M, Li Y, Choi AI, Deeks SG, Grunfeld C, et al. Association of tenofovir exposure with kidney disease risk in HIV infection. Aids. 2012; 26(7): 867-75. https://doi.org/10.1097/QAD.0b013e328351f68fRho M, Perazella MA. Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients. Current drug safety. 2007; 2(2): 147-54. https://doi.org/10.2174/157488607780598269Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, et al. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. The Journal of infectious diseases. 2008; 197(1): 102-8. https://doi.org/10.1086/524061Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, et al. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study. The lancet HIV. 2016; 3(1): e23-32. https://doi.org/10.1016/S2352-3018(15)00211-8Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS (London, England). 2012; 26(15): 1907-15. https://doi.org/10.1097/QAD.0b013e328357f5edPerrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clinical chemistry. 1992; 38(10): 1933-53. https://doi.org/10.1093/clinchem/38.10.1933Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985; 28(5): 830-8. https://doi.org/10.1038/ki.1985.205Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of internal medicine. 1999; 130(6): 461-70. https://doi.org/10.7326/0003-4819-130-6-199903160-00002Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annals of internal medicine. 2009; 150(9): 604-12. https://doi.org/10.7326/0003-4819-150-9-200905050-00006Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical chemistry. 2007; 53(4): 766-72. https://doi.org/10.1373/clinchem.2006.077180Vrouenraets SM, Fux CA, Wit FW, Garcia EF, Brinkman K, Hoek FJ, et al. A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clinical nephrology. 2012; 77(4): 311-20. https://doi.org/10.5414/CN107214Cristelli MP, Cofan F, Rico N, Trullas JC, Manzardo C, Aguero F, et al. Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis. BMC nephrology. 2017; 18(1): 58. https://doi.org/10.1186/s12882-017-0470-4Gagneux-Brunon A, Botelho-Nevers E, Delanaye P, Lucht F, Fresard A, Cazorla C, et al. CKD-EPI equation: A suitable Glomerular Filtration Rate estimate for drug dosing in HIV-infected patients. Medecine et maladies infectieuses. 2017. https://doi.org/10.1016/j.medmal.2017.04.001Okparavero AA, Tighiouart H, Krishnasami Z, Wyatt CM, Graham H, Hellinger J, et al. Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients. Antiviral therapy. 2013; 18(6): 793-802. https://doi.org/10.3851/IMP2676Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, et al. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2014; 59(9): e96-e138. https://doi.org/10.1093/cid/ciu617Andrassy KM. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. Kidney Int. 2013; 84(3): 622-3. https://doi.org/10.1038/ki.2013.243Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Annals of internal medicine. 2013; 158(11): 825-30. https://doi.org/10.7326/0003-4819-158-11-201306040-00007Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2014; 63(5): 713-35. https://doi.org/10.1053/j.ajkd.2014.01.416Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 2003; 289(19): 2560-72. https://doi.org/10.1001/jama.289.19.25602. Classification and Diagnosis of Diabetes. Diabetes care. 2017; 40(Suppl 1): S11-s24. https://doi.org/10.2337/dc17-S005Diaz K. PREVALENCIA DE ALTERACIÓN RENAL EN UNA POBLACIÓN AMBULATORIA CON VIH-SIDA DE CARTAGENA (TRABAJO DE GRADO). Universidad de Cartagena, Bolívar, Colombia. 2009.Costo FCdEdA. Situación de la Enfermedad Renal Crónica, la hipertensión arterial y la diabetes mellitus en Colombia 2016. Cuenta de Alto Costo. 2017: 57,107.Lamb EJ, O'Riordan SE, Delaney MP. Kidney function in older people: pathology, assessment and management. Clin Chim Acta. 2003; 334(1-2): 25-40. https://doi.org/10.1016/S0009-8981(03)00246-8Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic Kidney Disease Incidence, and Progression to End-Stage Renal Disease, in HIV-Infected Individuals: A Tale of Two Races. The Journal of infectious diseases. 2008; 197(11): 1548-57. https://doi.org/10.1086/587994Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV medicine. 2009; 10(6): 343-50. https://doi.org/10.1111/j.1468-1293.2009.00693.xFernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. The American journal of the medical sciences. 2008; 335(2): 89-94. https://doi.org/10.1097/MAJ.0b013e31812e6b34Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. Jama. 2007; 298(17): 2038-47. https://doi.org/10.1001/jama.298.17.2038Grams ME, Juraschek SP, Selvin E, Foster MC, Inker LA, Eckfeldt JH, et al. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2013; 62(2): 253-60. https://doi.org/10.1053/j.ajkd.2013.03.013Chapter 2: Definition, identification, and prediction of CKD progression. Kidney International Supplements. 2013; 3(1): 63-72. https://doi.org/10.1038/kisup.2012.65Winocour PH. Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care. Diabetic medicine : a journal of the British Diabetic Association. 2017. https://doi.org/10.1111/dme.13564Medapalli R, Parikh CR, Gordon K, Brown ST, Butt AA, Gibert CL, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: Data from the Veterans Aging Cohort Study. Journal of acquired immune deficiency syndromes (1999). 2012; 60(4): 393-9. https://doi.org/10.1097/QAI.0b013e31825b70d9Squires K, Pozniak AL, Pierone G, Jr., Steinhart CR, Berger D, Bellos NC, et al. Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection: a randomized trial. Annals of internal medicine. 2003; 139(5 Pt 1): 313-20. https://doi.org/10.7326/0003-4819-139-5_Part_1-200309020-00006Jones R, Stebbing J, Nelson M, Moyle G, Bower M, Mandalia S, et al. Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study. Journal of acquired immune deficiency syndromes (1999). 2004; 37(4): 1489-95. https://doi.org/10.1097/01.qai.0000138983.45235.02Kooij KW, Vogt L, Wit F, van der Valk M, van Zoest RA, Goorhuis A, et al. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. The Journal of infectious diseases. 2017; 216(6): 622-31. https://doi.org/10.1093/infdis/jix202Social MdSyP. Guía para el Manejo del VIH/SIDA - Basada en la Evidencia - COLOMBIA. 2014.Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodríguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. Aids. 2012; 26(15): 1907-15. https://doi.org/10.1097/QAD.0b013e328357f5edRevista Ciencias Biomédicas - 2019https://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2874Enfermedad renal crónicaVIHNefrotoxicidadChronic kidney insufficiencyHIVNephrotoxicityFactores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.Risk factors associated with chronic kidney disease in patients with HIV infection.Artículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlePublicationOREORE.xmltext/xml2560https://repositorio.unicartagena.edu.co/bitstreams/b06568d2-ffa3-4cc0-a27e-a00813b847fd/downloade5d59c61d1a32af919cc797efa562cb8MD5111227/13082oai:repositorio.unicartagena.edu.co:11227/130822024-09-05 15:30:42.308https://creativecommons.org/licenses/by-nc-sa/4.0/Revista Ciencias Biomédicas - 2019metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com

Factores de riesgo asociados a enfermedad renal crónica en pacientes con infección por VIH.

Publicaciones similares